Takeda Pharmaceutical
TAK
#491
Rank
โ‚น4.263 T
Marketcap
โ‚น1,281
Share price
0.28%
Change (1 day)
12.67%
Change (1 year)

Revenue for Takeda Pharmaceutical (TAK)

Revenue in 2025 (TTM): โ‚น2.553 Trillion

According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚น2.660 Trillion. In 2024 the company made a revenue of โ‚น2.566 Trillion an increase over the revenue in the year 2023 that were of โ‚น2.444 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Takeda Pharmaceutical from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น2.553 T-0.52%
2024 โ‚น2.566 T5.01%
2023 โ‚น2.444 T-0.33%
2022 โ‚น2.452 T6.58%
2021 โ‚น2.300 T4.18%
2020 โ‚น2.208 T4.3%
2019 โ‚น2.117 T87.55%
2018 โ‚น1.129 T11.12%
2017 โ‚น1.015 T-6.43%
2016 โ‚น1.085 T7.67%
2015 โ‚น1.008 T-1.08%
2014 โ‚น1.019 T-0.9%
2013 โ‚น1.028 T-2.42%
2012 โ‚น1.054 T7.82%
2011 โ‚น977.71 B32.59%
2010 โ‚น737.39 B2.28%
2009 โ‚น720.92 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.301 T 212.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.281 T 60.94%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚น5.656 T 112.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.078 T 90.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
โ‚น207.23 B-92.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
โ‚น356.54 B-86.60%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
โ‚น3.240 T 21.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น3.815 T 43.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น5.786 T 117.53%๐Ÿ‡บ๐Ÿ‡ธ USA